These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33153275)

  • 1. Systemic Inflammation Indices in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator: Clinical Yield and Utility.
    Topcuoglu MA; Pektezel MY; Yilmaz E; Arsava EM
    Angiology; 2021 Mar; 72(3):279-284. PubMed ID: 33153275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-to-Lymphocyte Ratio and Response to Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.
    Pektezel MY; Yilmaz E; Arsava EM; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1853-1859. PubMed ID: 31072698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlocking the potential of HB/RDW ratio as a simple marker for predicting mortality in acute ischemic stroke patients after thrombolysis.
    Krongsut S; Piriyakhuntorn P
    J Stroke Cerebrovasc Dis; 2024 Sep; 33(9):107874. PubMed ID: 39013504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in neutrophil, lymphocyte, platelet ratios and their relationship with NIHSS after rtPA and/or thrombectomy in ischemic stroke.
    Kömürcü HF; Gözke E; Doğan Ak P; Kalyoncu Aslan I; Salt I; Özgenç Bi Er Çİ
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):105004. PubMed ID: 32689579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Levels of Inflammation Markers Predict Poor Outcomes in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.
    Hu D; Ding C; Jiang X; Xiao J; Li C; Zhang L; Li T; Ji Y; Peng Y; Luo X; Sheng L; Wang Q; Wu H
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105587. PubMed ID: 33450606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA.
    Joo H; Wang G; George MG
    Stroke Vasc Neurol; 2016 Mar; 1(1):8-15. PubMed ID: 27547449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.
    You S; Saxena A; Wang X; Tan W; Han Q; Cao Y; Liu CF
    Stroke Vasc Neurol; 2018 Mar; 3(1):22-27. PubMed ID: 29600004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean Platelet Volume is a Prognostic Marker in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
    Dourado Sotero F; Calçada A; Aguiar de Sousa D; Dias M; Fonseca AC; Pinho E Melo T; Canhão P
    J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105718. PubMed ID: 33838517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerotic intracranial internal carotid artery calcification and intravenous thrombolytic therapy for acute ischemic stroke.
    Gocmen R; Arsava EM; Oguz KK; Topcuoglu MA
    Atherosclerosis; 2018 Mar; 270():89-94. PubMed ID: 29407893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective.
    Bai QK; Zhao ZG; Lu LJ; Shen J; Zhang JY; Sui HJ; Xie XH; Chen J; Yang J; Chen CR
    Stroke Vasc Neurol; 2019 Mar; 4(1):8-13. PubMed ID: 31105973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Clot Volume and Permeability on Response to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke.
    Bilgic AB; Gocmen R; Arsava EM; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104541. PubMed ID: 31810719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
    Tsuruoka A; Atsumi C; Mizukami H; Imai T; Hagiwara Y; Hasegawa Y
    J Stroke Cerebrovasc Dis; 2014; 23(10):2894-2899. PubMed ID: 25282183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.
    Joo H; Wang G; George MG
    Stroke Vasc Neurol; 2017; 2(2):73-83. PubMed ID: 28736623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
    Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
    Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?
    Dong Y; Cao W; Cheng X; Fang K; Wu F; Yang L; Xie Y; Dong Q
    Stroke Vasc Neurol; 2016 Sep; 1(3):115-121. PubMed ID: 28959472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Stroke-Associated Infection and other Readily Available Parameters in Acute Ischemic Stroke Treated by Intravenous Thrombolysis.
    Derbisz J; Nowak K; Wnuk M; Pulyk R; Jagiella J; Slowik J; Dziedzic T; Slowik A
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105525. PubMed ID: 33338755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S; Liang L; Kosinski A; Hernandez AF; Schwamm LH; Smith EE; Fonarow GC; Bhatt DL; Feng W; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of early post-treatment single-photon emission computed tomography imaging to predict outcome in stroke patients treated with intravenous tissue plasminogen activator.
    Abumiya T; Katoh M; Moriwaki T; Yoshino M; Aoki T; Imamura H; Aida T; Scichinohe H; Nakayama N; Kazumata K; Houkin K
    J Stroke Cerebrovasc Dis; 2014; 23(5):896-901. PubMed ID: 24045082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.